Literature DB >> 15170047

Prophylactic antibiotic treatment of bronchiectasis with azithromycin.

G Davies, R Wilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15170047      PMCID： PMC1747020     

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  18 in total

1.  CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters.

Authors:  L J Maarschalk-Ellerbroek; P A de Jong; J M van Montfrans; J W J Lammers; A C Bloem; A I M Hoepelman; P M Ellerbroek
Journal:  J Clin Immunol       Date:  2014-06-21       Impact factor: 8.317

Review 2.  Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.

Authors:  P Zarogoulidis; N Papanas; I Kioumis; E Chatzaki; E Maltezos; K Zarogoulidis
Journal:  Eur J Clin Pharmacol       Date:  2011-11-22       Impact factor: 2.953

3.  Development of a population pharmacokinetic model to describe azithromycin whole-blood and plasma concentrations over time in healthy subjects.

Authors:  T Pene Dumitrescu; T Anic-Milic; K Oreskovic; J Padovan; K L R Brouwer; P Zuo; V D Schmith
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

4.  Asthma and Hypogammaglobulinemia: an Asthma Phenotype with Low Type 2 Inflammation.

Authors:  Clairelyne Dupin; Sylvain Marchand-Adam; Olivier Favelle; Romain Costes; Philippe Gatault; Philippe Diot; Leslie Grammatico-Guillon; Laurent Guilleminault
Journal:  J Clin Immunol       Date:  2016-10-06       Impact factor: 8.317

Review 5.  Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?

Authors:  Paul King
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 6.  Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review.

Authors:  Katrine Fjaellegaard; Melda Dönmez Sin; Andrea Browatzki; Charlotte Suppli Ulrik
Journal:  Chron Respir Dis       Date:  2016-08-09       Impact factor: 2.444

Review 7.  Clinical immunology review series: An approach to the management of pulmonary disease in primary antibody deficiency.

Authors:  M D Tarzi; S Grigoriadou; S B Carr; L M Kuitert; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2009-02       Impact factor: 4.330

Review 8.  Use of azithromycin in the treatment of acute exacerbations of COPD.

Authors:  Aaron P Milstone
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 9.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 10.  The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis.

Authors:  R Masekela; R J Green
Journal:  Mediators Inflamm       Date:  2012-04-18       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.